Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement

The optimal design and patient selection for interventional trials in radiogenomics seem trivial at first sight. However, radiogenomics do not give binary information like in e.g. targetable mutation biomarkers. Here, the risk to develop severe side effects is continuous, with increasing incidences...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiother Oncol
Main Authors: De Ruysscher, Dirk, Defraene, Gilles, Ramaekers, Bram L.T., Lambin, Philippe, Briers, Erik, Stobart, Hilary, Ward, Tim, Bentzen, Søren M, Van Staa, Tjeerd, Azria, David, Rosenstein, Barry, Kerns, Sarah, West, Catharine
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5557371/
https://ncbi.nlm.nih.gov/pubmed/27979370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2016.11.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados